Daniel SimãoHead of the Bayer Pharma Lab at iBET – Instituto de Biologia Experimental e TecnológicaSpeaker
Profile
Daniel Simão is Head of the Bayer Pharma Satellite Lab within the Animal Cell Technology Unit at iBET. He holds a PhD in Bioengineering Systems from the MIT‑Portugal Program and has expertise spanning advanced human cell models, gene therapy vectors, and antibody discovery and characterization. He coordinates a team contributing to industry‑driven R&D projects in biologics, supporting antibody selection, expression platform development, and assay development. His academic research focuses on immune–tissue crosstalk in cardiovascular disease using human iPSC‑derived models.
Agenda Sessions
Decoding Macrophage–Fibroblast Crosstalk to Enable Next-Generation Anti-fibrotic Therapies
, 14:00View Session
